Stoyanova Lab News
Development of a new method for the quantification of cancer invasion and migration ability
Stoyanova Lab developed a novel 3D Matrigel-based experimental techniques for the quantification of cancer migration and invasion. Congratulations, Merve and team.
https://academic.oup.com/biomethods/article/6/1/bpab014/6325081
Discovery of MCM2-7 complex is new therapeutic target for neuroendocrine prostate cancer
Exiting new study from our lab identifies MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer. Congratulations En-chi and team!
Exciting news: Dr. Busola Alabi joins Stoyanova lab!
Welcome to the team Busola!
Laura received Justice, Diversity, Equity & Inclusion Seed Grants. “Developing Stanford-Clark Atlanta University Research Program”
Project Lead: Shiqin Liu, Team Members: Merve Aslan, Tanya Stoyanova
Congratulations Laura and team!
https://med.stanford.edu/radiology/news/2021/justice-diversity-equity-inclusion-seed-grants.html
Exciting news: Dr. Manoj Kumar awarded Sanjiv Sam Gambhir – PHILIPS Fellowship in Precision Medicine (PHIND) for “Development of Trop2 Targeted PET-imaging Probe and Therapy for Cancer.” He is a Postdoctoral Research Fellow in Stoyanova Lab.
Congratulations Manoj!
https://canarycenter.stanford.edu/news-events/canary-news/202-philips-fellowship.html
Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay
Exiting new study from our lab suggest that CASP8 may serve as a biomarker for high-risk prostate cancer and potentially renal cancer. Congratulations Laura and team.
New review article on the role of Trop2 in prostate cancer
Stoyanova Lab publishes a review article discussing the role of Trop2 in prostate cancer. Congratulations Michelle!
Developing new imaging approach for methionine aminopeptidase II for prostate cancer risk stratification
Exciting new results from our lab collaborative work reveal a new imaging approach for risk stratification of prostate cancer.
Dr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant
Dr. Demirci and Dr. Stoyanova receive Spectrum MedTech Pilot Grant
“An automated disposable tool for liquid biopsy-based detection of exosomal biomarkers for early cancer detection”